TITLE

The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast

AUTHOR(S)
G M Tse
PUB. DATE
May 2009
SOURCE
Journal of Clinical Pathology;May2009, Vol. 62 Issue 5, p407
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Papillary lesions of the breast represent a heterogeneous group with differing biological behaviour. Correct diagnosis is crucial but may be difficult, as many benign and malignant papillary lesions have similar appearances. Immunohistochemistry plays a useful role in their differentiation. Myoepithelial markers can help in differentiating papilloma from papillary carcinoma, as the former usually shows a continuous layer of myoepithelial cells. In intracystic papillary carcinoma, there is controversy as to the presence of a complete myoepithelial cell layer around these lesions. p63 is the marker of choice as the staining is nuclear, cross-reactivity is minimal, and sensitivity is high. Papilloma may frequently be complicated by superimposed different types of epithelial hyperplasia, which range from usual to atypical or even ductal carcinoma in situ, and they many be morphologically similar. Basal cytokeratins (CKs) are useful to differentiate these entities; as usual hyperplasia is positive for basal CKs with a mosaic staining pattern. CK5/6 is probably the best marker. Neuroendocrine markers (chromogranin A and synaptophysin) may be positive in papillary carcinoma, particularly in the solid type, and there may be some overlap with the ductal carcinoma in situ with spindle cells or endocrine ductal carcinoma in situ. A panel of CK5/6, p63 and neuroendocrine markers can be useful in the diagnostic investigation of problematic papillary lesions of the breast. As the experience with these markers remains rather limited, it is too early to recommend basing treatment choices on these marker studies alone. Complete removal of lesion is probably still the treatment of choice.
ACCESSION #
38420159

 

Related Articles

  • Carcinoma de mama con c�lulas gigantes tipo osteoclasto. Informe de un caso de una variante rara. Murgu�a-P�rez, Mario; Dur�n-Padilla, Marco Antonio; Cruz-Gordillo, Ana Guadalupe; Trejo-Pantoja, Jos� Antonio; Mendoza-Ram�rez, Saulo // Revista Espa�ola de Patolog�a;oct-dic2012, Vol. 45 Issue 4, p230 

    Breast carcinoma with osteoclast-like giant cells (BCOGC) is a rare, distinctive form of breast cancer. Although cases have been reported with many growth patterns in almost all types of breast cancer, being rarely found in well differentiated tumours. We report a case of well-differentiated...

  • The expression and prognostic significance of the tumour-associated glycoprotein 72 in the normal, hyperplastic and neoplastic endometrium using immunohistochemical methods. Mızrak, Tolga; Uysal, Ahmet; Eftal Taner, Cüneyt; Bayol, Ümit // Menopausal Review / Przeglad Menopauzalny;2013, Vol. 17 Issue 3, p202 

    Aim of the study: Our aim was to investigate the expression and the prognostic significance of tumourassociated glycoprotein 72 (TAG-72), which is an epithelial tumour marker, using immunohistochemical methods in the normal, hyperplastic and neoplastic endometrium. Material and methods: The...

  • IMMUNOHISTOCHEMICAL METHODS IN DIFFERENTIAL DIAGNOSIS OF DUCTAL AND LOBULAR BREAST CARCINOMAS IN SITU. D., Efremov G.; E., Zavalishina L.; A., Frank G. // Oncosurgery / Onkohirurgia;2012, Vol. 4 Issue 2, p26 

    The objective was to determine the most efficient combination of biological characteristics for differential diagnosis between ductal and lobular carcinoma in situ, especially in the case of uncommon morphological structure of tumor. Materials and methods. The study group included 99 patients...

  • Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients. El Agouza, I.; Eissa, S.; El Houseini, M.; El-Nashar, Dalia; Abd El Hameed, O. // Angiogenesis;Sep2011, Vol. 14 Issue 3, p321 

    Introduction: The antioxidant Taurine found to display antineoplastic effect through down regulation of angiogenesis and enhancement of tumor cell apoptosis. It has been found that progressive inhibition of apoptosis and induction of angiogenesis may contribute to tumor initiation, growth and...

  • An Immunohistochemical Panel to Differentiate Metastatic Breast Carcinoma to Skin From Primary Sweat Gland Carcinomas With a Review of the Literature. Rollins-Raval, Marian; Chivukula, Mamatha; Tseng, George C.; Jukic, Drazen; Dabbs, David J. // Archives of Pathology & Laboratory Medicine;Aug2011, Vol. 135 Issue 8, p975 

    Context.--Approximately 25% of patients with breast cancer develop cutaneous metastases. Sweat gland carcinomas (SGCs) account for about 0.05% of all cutaneous neoplasms. Cutaneous metastases of breast carcinoma (CMBCs) (especially the ductal type) can be difficult to distinguish from SGCs....

  • Epithelioid Lesions of the Serosa. Anttila, Sisko // Archives of Pathology & Laboratory Medicine;Mar2012, Vol. 136 Issue 3, p241 

    Context.-Diagnosing epithelioid serosal lesions remains a challenge because numerous different processes-primary or secondary, benign or malignant-occur in body cavities, some of which are very rare. Objectives.-To review the newest literature and to describe the morphologic criteria and...

  • Pathology of Breast Carcinomas After Neoadjuvant Chemotherapy. Sahoo, Sunati; Lester, Susan C. // Archives of Pathology & Laboratory Medicine;Apr2009, Vol. 133 Issue 4, p633 

    Context.-Currently, more women are being treated with chemotherapy or hormonal agents before surgery (neoadjuvant chemoendocrine therapy) for earlier-stage operable breast carcinoma. The pathologic examination of these specimens can be quite challenging. Objective.-To give an overview of (1)...

  • Detection and diagnosis.  // Annals of Oncology;Mar2011 Supplement 2, Vol. 22 Issue suppl_2, pii37 

    No abstract available.

  • Intraductal Proliferative Lesions of the Breast-Terminology and Biology Matter: Premalignant Lesions or Preinvasive Cancer? Costarelli, Leopoldo; Campagna, Domenico; Mauri, Maria; Fortunato, Lucio // International Journal of Surgical Oncology;2012, p1 

    Morphological criteria for the diagnosis of intraductal proliferative lesions of the breast have been an object of research and much controversy, and its terminology is rather confusing. Knowledge of the molecular aspects of this disease probably necessitates further research to clarify if these...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics